

A Breakthrough test for Endometrial Cancer: Accurate, Rapid & Simple.
What is WID®-easy?
How does it work?
WID-easy is a genetic test for the early detection of womb cancer for women and people suffering from abnormal uterine bleeding, during or after menopause. The WID-easy test saves many patients from having to undergo invasive surgery to diagnose whether cancer is the cause of the bleeding.
WID-easy measures chemical modifications of your DNA from your cervix and womb, which indicates the presence or absence of cancer cells. The sample collection involves a quick and painless vaginal swab, which is then sent to a lab for analysis using PCR (like a Covid test).
WID-easy helps you make the most informed decision for the next steps in your care, and avoid unnecessary invasive procedures.
Every year in the UK, around 300,000 peri- and post-menopausal women experience abnormal uterine bleeding 2. These women are given an ultrasound scan to check for signs of cancer, which if found, will trigger further testing. These tests often involve highly invasive procedures, such as hysteroscopy and curettage.
9 in 10 patients referred for these procedures do not have womb cancer 1. The WID-easy test has been shown to detect the same number of women with cancer as ultrasound, while reducing the number of false positive results (“false alarms”) by 90% 1.

Key Benefits
Accurate
Rapid
Painless
Simple
Literature and Resources
FAQs